Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! By
Impact of Serum Ferritin and Iron Overload on Acute Myeloid Leukemia Outcomes: A Systematic Review and Meta-Analysis Publisher Pubmed



S Sadighi SANAMBAR ; E Sahinoglu EFE ; Ah Kubba Ahmed HAIDER ; J Patel JHANVI ; F Hosseini FOROUGH ; Mas Shafiee Mohammad Ali S ; B Qureshi BAKHTAVAR
Authors

Source: Asian Pacific Journal of Cancer Prevention Published:2024


Abstract

Objective: To evaluate the iron overload among individuals with acute myeloid leukemia (AML) who have not received red blood cell transfusions. Methods: A comprehensive search was conducted in Embase, PubMed, PubMed Central, Web of Science, NIH, and Blood Library databases up to September 2023. The search strategy included keywords related to AML, iron overload, serum ferritin, survival, outcomes, and inflammation. Manual searches through included articles and relevant references were also performed. From 1650 initial articles, 16 studies involving 8752 patients met the inclusion criteria for systematic review. Statistical analysis used hazard ratios (HR) and confidence intervals (CI). Results: The systematic review and meta-analysis revealed a statistically significant association between high serum ferritin (SF) levels and poor outcomes in AML patients before starting chemotherapy. Elevated SF levels (>1000 mg/L) were associated with lower overall survival (OS) and event-free survival (EFS) (HR for OS: 1.99, 95% CI: 1.48–2.66; HR for EFS: 2.29, 95% CI: 1.73–3.05). Elevated SF levels were inversely correlated with the gradual onset of infections, indicating an increased risk of early mortality (p<0.05). Conclusion: Elevated serum ferritin levels are significantly associated with poor outcomes in AML patients before treatment initiation. These findings highlight the importance of monitoring iron levels in these patients to improve prognostic assessments and treatment strategies. © 2024 Elsevier B.V., All rights reserved.
Related Docs
View other Related Docs
1. Effect of Combined Versus Monotherapy With Deferoxamine and Deferiprone in Iron Overloaded Thalassemia Patients: A Randomized Clinical Trial, International Journal of Pediatrics (2016)
2. Serum Ferritin Levels and Irregular Use of Iron Chelators Predict Liver Iron Load in Patients With Major Beta Thalassemia: A Cross-Sectional Study, Croatian Medical Journal (2019)
3. Immunotherapy in Aml: A Brief Review on Emerging Strategies, Clinical and Translational Oncology (2021)
Experts (# of related papers)
View all Related Experts
Mohammad Vaezi (4)
Kheirollah Gholami (2)
Other Related Docs
4. Iron Deficiency and Anemia in Cancer Patients: The Role of Iron Treatment in Anemic Cancer Patients, Nutrition and Cancer (2020)
5. Oral Calcitriol in Hematopoietic Recovery and Survival After Autologous Stem Cell Transplantation: A Randomized Clinical Trial, DARU# Journal of Pharmaceutical Sciences (2019)
6. The Effect of Quercetin on Iron Overload and Inflammation in Β-Thalassemia Major Patients: A Double-Blind Randomized Clinical Trial, Complementary Therapies in Medicine (2019)
7. Iron; the Missing Link of Depression Prevention and Treatment: A Systematic Review and Meta-Analysis, Journal of Biostatistics and Epidemiology (2024)
8. High Prevalence of Vitamin D Deficiency in Newly Diagnosed Acute Myeloid Leukemia Patients and Its Adverse Outcome, International Journal of Hematology-Oncology and Stem Cell Research (2017)
9. Evaluation of Serum Transferrin Receptors in Children With Iron Deficiency Anemia, Acta Medica Mediterranea (2016)
10. The Effectiveness of Anemia Treatment With Injectable Iron Within 48 to 72 Hours Before Coronary Artery Bypass Surgery on Cardiac Function and Postoperative Outcome: A Randomized Clinical Trial, Journal of Iranian Medical Council (2024)
11. Prognostic Value of Red Blood Cell Distribution Width and D-Dimer in Diffuse Large B-Cell Lymphoma: Systematic Review and Meta-Analysis, Cancer Reports (2024)
12. Cross-Sectional and Longitudinal Associations of Iron Biomarkers and Cardiovascular Risk Factors in Pre- and Postmenopausal Women: Leveraging Repeated Measurements to Address Natural Variability, Cardiovascular Diabetology (2024)
13. Comparison of 60 and 80Mg/M2 of Daunorubicin in Induction Therapy of Acute Myeloid Leukaemia, Hematological Oncology (2017)
14. Myeloablative Conditioning for Allo-Hsct in Pediatric All: Ftbi or Chemotherapy?—A Multicenter Ebmt-Pdwp Study, Bone Marrow Transplantation (2020)
15. The Association of Pro-Oxidant/Antioxidant Balance and Blood Parameters in Patients With Beta-Thalassemia Major: A Cross-Sectional Study, Blood Research (2023)
16. Syringic Acid Attenuates Oxidative Stress in Plasma and Peripheral Blood Mononuclear Cells of Patients With Acute Myeloid Leukemia, Nutrition and Cancer (2023)
17. Correlation Between Heart and Liver Iron Levels Measured by Mri T2* and Serum Ferritin in Patients With Β-Thalassemia Major, International Journal of Pediatrics (2016)
18. A Single Center Study of Prescribing and Treatment Outcomes of Patients With Chronic Myeloid Leukemia, International Journal of Hematology-Oncology and Stem Cell Research (2020)
19. Dietary Iron Intake and the Risk of Type 2 Diabetes: A Systematic Review and Dose–Response Meta-Analysis of Prospective Cohort Studies, European Journal of Nutrition (2022)
20. Survival of Patients With Acute Myeloid Leukemia After Allogeneic Stem Cell Transplantation: An Experience in Developing Country, International Journal of Hematology-Oncology and Stem Cell Research (2022)